Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Allen

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Developmental Medicine and Child Neurology|June 27, 2007
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetineJoachim F Wernicke, Karen Chilcott Holdridge, Ling Jin, et al.
Psychiatry Research|January 16, 2013
Validity of conners' adult attention-deficit/hyperactivity disorder rating Scale-investigator rated: screening version in patients from within and outside of EuropeJ J Sandra Kooij, C Keith Conners, Taro Goto, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizersCorina Loghin, Harry Haber, Charles M Beasley, et al.
Journal of Attention Disorders|November 9, 2013
Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHDTaro Goto, Yuko Hirata, Yasushi Takita, et al.
Biological Psychiatry|January 28, 2003
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesDavid Michelson, Lenard Adler, Thomas Spencer, et al.
Clinical Therapeutics|August 19, 2007
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy studyHumberto Quintana, Edward A Cherlin, David A Duesenberg, et al.
Journal of Child and Adolescent Psychopharmacology|August 26, 2009
A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorderMichihiro Takahashi, Yasushi Takita, Kosuke Yamazaki, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorderJorge M Tamayo, Andres Pumariega, Eugenio M Rothe, et al.
Journal of Attention Disorders|October 31, 2007
Functional outcomes in the treatment of adults with ADHDLenard A Adler, Thomas J Spencer, Louise R Levine, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorderJeffrey H Newcorn, Virginia K Sutton, Shuyu Zhang, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Developmental Medicine and Child Neurology|June 27, 2007
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetineJoachim F Wernicke, Karen Chilcott Holdridge, Ling Jin, et al.
Psychiatry Research|January 16, 2013
Validity of conners' adult attention-deficit/hyperactivity disorder rating Scale-investigator rated: screening version in patients from within and outside of EuropeJ J Sandra Kooij, C Keith Conners, Taro Goto, et al.
British Journal of Clinical Pharmacology|July 19, 2012
Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizersCorina Loghin, Harry Haber, Charles M Beasley, et al.
Journal of Attention Disorders|November 9, 2013
Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHDTaro Goto, Yuko Hirata, Yasushi Takita, et al.
Biological Psychiatry|January 28, 2003
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesDavid Michelson, Lenard Adler, Thomas Spencer, et al.
Clinical Therapeutics|August 19, 2007
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy studyHumberto Quintana, Edward A Cherlin, David A Duesenberg, et al.
Journal of Child and Adolescent Psychopharmacology|August 26, 2009
A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorderMichihiro Takahashi, Yasushi Takita, Kosuke Yamazaki, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorderJorge M Tamayo, Andres Pumariega, Eugenio M Rothe, et al.
Journal of Attention Disorders|October 31, 2007
Functional outcomes in the treatment of adults with ADHDLenard A Adler, Thomas J Spencer, Louise R Levine, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorderJeffrey H Newcorn, Virginia K Sutton, Shuyu Zhang, et al.
Pageof 6